Home » Stocks » Kitov Pharma

Kitov Pharma Ltd. (KTOV)

Stock Price: $0.752 USD -0.028 (-3.59%)
Updated Aug 12, 2020 12:30 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 129.42M
Revenue (ttm) 1,000,000
Net Income (ttm) -5.89M
Shares Out 162.87M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $0.752
Previous Close $0.780
Change ($) -0.028
Change (%) -3.59%
Day's Open 0.790
Day's Range 0.750 - 0.793
Day's Volume 5,181,641
52-Week Range 0.220 - 1.440

More Stats

Market Cap 129.42M
Enterprise Value 123.25M
Earnings Date (est) Feb 11, 2021
Ex-Dividend Date n/a
Shares Outstanding 162.87M
Float 33.47M
EPS (basic) -0.3
EPS (diluted) -0.30
FCF / Share -0.29
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 6.52M
Short Ratio 0.24
Short % of Float n/a
Beta 2.48
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 129.42
PB Ratio 14.03
Revenue 1,000,000
Operating Income -7.16M
Net Income -5.89M
Free Cash Flow -5.59M
Net Cash 6.17M
Net Cash / Share 0.04
Gross Margin 100.00%
Operating Margin -715.60%
Profit Margin -589.30%
FCF Margin -559.20%
ROA -28.87%
ROE -53.91%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

Current: $0.752
Target: 3.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth0%900%-----
Gross Profit1.001.000.10----
Operating Income-7.16-7.83-11.97-7.18-4.07-4.46-2.55
Net Income-5.89-5.57-12.91-12.13-4.20-5.25-2.63
Shares Outstanding19.3714.219.465.760.960.220.08
Earnings Per Share-0.30-0.39-1.37-2.11-4.40-23.40-32.00
Operating Cash Flow-5.58-8.48-8.63-6.26-3.31-4.53-0.51
Capital Expenditures-0.01-0.02-0.01-0.01-0.01--
Free Cash Flow-5.59-8.50-8.64-6.27-3.32-4.53-0.51
Cash & Equivalents6.406.687.4414.6610.561.310.00
Total Debt0.220.552.01-0.140.37-
Net Cash / Debt6.176.135.4214.6610.420.940.00
Book Value10.4210.527.4113.399.430.77-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Kitov Pharma Ltd.
Country Israel
Employees 9
CEO Isaac Israel

Stock Information

Ticker Symbol KTOV
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: KTOV


Kitov Pharma Ltd, a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharmaceuticals Holdings Ltd. and changed its name to Kitov Pharma Ltd in January 2018. Kitov Pharma Ltd is headquartered in Tel Aviv, Israel.